Related Experiment Video

Updated: May 25, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of

Takuya Matsunaga1, Naofumi Takemoto, Tsutomu Sato

  • 1Fourth Department of Internal Medicine, Sapporo Medical University School of Medicine, South-1, West-16, Chuo-ku, Sapporo 060-0061, Japan.

Nature Medicine
|August 5, 2003
PubMed

Insights

Minimal residual disease (MRD) in acute myelogenous leukemia (AML) bone marrow causes relapse. Targeting VLA-4 on leukemia cells with antibodies, combined with chemotherapy, significantly improves survival by overcoming drug resistance.

Area of Science:

  • Hematology
  • Cancer Biology
  • Immunology

Background:

  • Minimal residual disease (MRD) in acute myelogenous leukemia (AML) is a primary cause of relapse post-chemotherapy.
  • Leukemic cell adhesion to bone marrow stromal cells via very late antigen-4 (VLA-4) and fibronectin interaction is implicated in drug resistance.

Purpose of the Study:

  • To investigate the role of VLA-4 and fibronectin interaction in mediating chemoresistance in AML.
  • To evaluate the therapeutic potential of VLA-4 blockade in overcoming MRD-induced relapse.

Main Methods:

  • Analysis of VLA-4 expression on leukemic cells and its correlation with drug resistance.
  • Investigation of the phosphatidylinositol-3-kinase (PI-3K)/AKT/Bcl-2 signaling pathway activation.
  • Assessment of VLA-4-specific antibodies and cytosine arabinoside (AraC) combination therapy in a mouse MRD model.
  • Clinical correlation of VLA-4 expression with patient survival outcomes.

Main Results:

  • VLA-4-positive AML cells exhibited resistance to anoikis and drug-induced apoptosis, mediated by the PI-3K/AKT/Bcl-2 pathway.
  • VLA-4 blockade with specific antibodies reversed this chemoresistance.
  • Combination therapy of VLA-4 antibodies and AraC resulted in 100% survival in a mouse MRD model.
  • VLA-4-negative AML patients showed significantly better 5-year overall survival (100%) compared to VLA-4-positive patients (44.4%).

Conclusions:

  • The VLA-4/fibronectin axis is critical for bone marrow MRD in AML, contributing to therapeutic resistance.
  • Targeting VLA-4 presents a promising strategy to overcome MRD and improve AML patient prognosis.
  • VLA-4 expression serves as a potential prognostic biomarker for AML patients.

More Related Videos

Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact11:29

Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact

Published on: July 17, 2016

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery07:20

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery

Published on: February 28, 2020

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Fibronectins Connect Cells with ECM01:25

Fibronectins Connect Cells with ECM

Fibronectin is an adhesive glycoprotein present in the extracellular matrix of embryogenic and adult tissue. These molecules primarily aid in regulating cell motility and attachment. A fibronectin molecule is composed of two identical polypeptide chains attached to each other by a pair of disulfide bonds at the C-terminal.
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...